Annual CFI
-$4.10 B
-$5.68 B-360.12%
December 31, 2023
Summary
- As of February 7, 2025, BIIB annual cash flow from investing activities is -$4.10 billion, with the most recent change of -$5.68 billion (-360.12%) on December 31, 2023.
- During the last 3 years, BIIB annual CFI has fallen by -$3.49 billion (-573.84%).
- BIIB annual CFI is now -360.12% below its all-time high of $1.58 billion, reached on December 31, 2022.
Performance
BIIB Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$1.18 B
-$1.65 B-353.18%
September 30, 2024
Summary
- As of February 7, 2025, BIIB quarterly cash flow from investing activities is -$1.18 billion, with the most recent change of -$1.65 billion (-353.18%) on September 30, 2024.
- Over the past year, BIIB quarterly CFI has dropped by -$1.65 billion (-353.18%).
- BIIB quarterly CFI is now -170.63% below its all-time high of $1.67 billion, reached on September 30, 2022.
Performance
BIIB Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$1.43 B
+$561.10 M+28.14%
September 30, 2024
Summary
- As of February 7, 2025, BIIB TTM cash flow from investing activities is -$1.43 billion, with the most recent change of +$561.10 million (+28.14%) on September 30, 2024.
- Over the past year, BIIB TTM CFI has increased by +$561.10 million (+28.14%).
- BIIB TTM CFI is now -189.28% below its all-time high of $1.60 billion, reached on September 30, 2022.
Performance
BIIB TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
BIIB Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -360.1% | -353.2% | +28.1% |
| 3 y3 years | -573.8% | -353.2% | +28.1% |
| 5 y5 years | -100.4% | -353.2% | +28.1% |
BIIB Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -360.1% | at low | -170.6% | +32.2% | -189.3% | +65.1% |
| 5 y | 5-year | -360.1% | at low | -170.6% | +32.2% | -189.3% | +65.1% |
| alltime | all time | -360.1% | +9.9% | -170.6% | +34.7% | -189.3% | +72.7% |
Biogen Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.18 B(-353.2%) | -$1.43 B(-28.1%) |
| Jun 2024 | - | $466.50 M(-806.8%) | -$1.99 B(-38.0%) |
| Mar 2024 | - | -$66.00 M(-89.9%) | -$3.21 B(-21.6%) |
| Dec 2023 | -$4.10 B(-360.1%) | -$652.30 M(-62.6%) | -$4.10 B(+14.2%) |
| Sep 2023 | - | -$1.74 B(+131.2%) | -$3.59 B(+1946.6%) |
| Jun 2023 | - | -$753.50 M(-20.9%) | -$175.40 M(-113.8%) |
| Mar 2023 | - | -$953.00 M(+575.4%) | $1.27 B(-19.3%) |
| Dec 2022 | $1.58 B(-379.7%) | -$141.10 M(-108.4%) | $1.58 B(-1.8%) |
| Sep 2022 | - | $1.67 B(+141.1%) | $1.60 B(-633.6%) |
| Jun 2022 | - | $693.50 M(-207.0%) | -$300.80 M(-73.8%) |
| Mar 2022 | - | -$648.00 M(+475.0%) | -$1.15 B(+103.5%) |
| Dec 2021 | -$563.70 M(-7.4%) | -$112.70 M(-51.8%) | -$563.70 M(-8.7%) |
| Sep 2021 | - | -$233.60 M(+53.0%) | -$617.40 M(+41.5%) |
| Jun 2021 | - | -$152.70 M(+136.0%) | -$436.20 M(-60.9%) |
| Mar 2021 | - | -$64.70 M(-61.1%) | -$1.12 B(+83.4%) |
| Dec 2020 | -$608.60 M(-229.4%) | -$166.40 M(+217.6%) | -$608.60 M(-328.6%) |
| Sep 2020 | - | -$52.40 M(-93.7%) | $266.20 M(-662.8%) |
| Jun 2020 | - | -$832.70 M(-288.0%) | -$47.30 M(-107.0%) |
| Mar 2020 | - | $442.90 M(-37.5%) | $674.60 M(+43.4%) |
| Dec 2019 | $470.50 M(-123.0%) | $708.40 M(-293.6%) | $470.50 M(-125.3%) |
| Sep 2019 | - | -$365.90 M(+230.2%) | -$1.86 B(-12.0%) |
| Jun 2019 | - | -$110.80 M(-146.4%) | -$2.12 B(-32.9%) |
| Mar 2019 | - | $238.80 M(-114.7%) | -$3.15 B(+54.1%) |
| Dec 2018 | -$2.05 B(-30.9%) | -$1.63 B(+162.5%) | -$2.05 B(+71.9%) |
| Sep 2018 | - | -$619.10 M(-46.1%) | -$1.19 B(-34.5%) |
| Jun 2018 | - | -$1.15 B(-185.3%) | -$1.82 B(+108.4%) |
| Mar 2018 | - | $1.35 B(-275.0%) | -$872.30 M(-70.6%) |
| Dec 2017 | -$2.96 B(+19.2%) | -$769.50 M(-38.3%) | -$2.96 B(+6.8%) |
| Sep 2017 | - | -$1.25 B(+515.8%) | -$2.78 B(+86.0%) |
| Jun 2017 | - | -$202.50 M(-72.8%) | -$1.49 B(-26.3%) |
| Mar 2017 | - | -$744.20 M(+27.9%) | -$2.03 B(-18.5%) |
| Dec 2016 | -$2.48 B(-45.4%) | -$581.70 M(-1706.9%) | -$2.48 B(-33.0%) |
| Sep 2016 | - | $36.20 M(-104.9%) | -$3.71 B(-21.7%) |
| Jun 2016 | - | -$736.10 M(-38.8%) | -$4.74 B(-9.8%) |
| Mar 2016 | - | -$1.20 B(-33.4%) | -$5.25 B(+15.4%) |
| Dec 2015 | -$4.55 B(+195.1%) | -$1.81 B(+82.6%) | -$4.55 B(+45.7%) |
| Sep 2015 | - | -$990.00 M(-21.0%) | -$3.12 B(+16.8%) |
| Jun 2015 | - | -$1.25 B(+149.3%) | -$2.67 B(+30.4%) |
| Mar 2015 | - | -$502.80 M(+32.9%) | -$2.05 B(+33.0%) |
| Dec 2014 | -$1.54 B(-3.8%) | -$378.30 M(-30.0%) | -$1.54 B(-17.7%) |
| Sep 2014 | - | -$540.56 M(-14.2%) | -$1.87 B(+13.0%) |
| Jun 2014 | - | -$630.13 M(<-9900.0%) | -$1.66 B(-5.5%) |
| Mar 2014 | - | $5.99 M(-100.8%) | -$1.75 B(+9.3%) |
| Dec 2013 | -$1.60 B(+68.9%) | -$710.01 M(+118.9%) | -$1.60 B(+26.3%) |
| Sep 2013 | - | -$324.39 M(-55.3%) | -$1.27 B(-13.5%) |
| Jun 2013 | - | -$726.24 M(-565.7%) | -$1.47 B(+84.7%) |
| Mar 2013 | - | $155.94 M(-141.5%) | -$795.02 M(-16.3%) |
| Dec 2012 | -$950.34 M(-42.4%) | -$375.45 M(-28.1%) | -$950.34 M(-1.5%) |
| Sep 2012 | - | -$522.39 M(+883.5%) | -$964.42 M(-6.3%) |
| Jun 2012 | - | -$53.12 M(-8694.8%) | -$1.03 B(-32.4%) |
| Mar 2012 | - | $618.00 K(-100.2%) | -$1.52 B(-7.7%) |
| Dec 2011 | -$1.65 B(-577.9%) | -$389.53 M(-33.7%) | -$1.65 B(-7.3%) |
| Sep 2011 | - | -$587.18 M(+7.4%) | -$1.78 B(+41.0%) |
| Jun 2011 | - | -$546.79 M(+331.2%) | -$1.26 B(+3943.8%) |
| Mar 2011 | - | -$126.80 M(-75.6%) | -$31.21 M(-109.0%) |
| Dec 2010 | $345.32 M(-187.4%) | -$518.62 M(+643.5%) | $345.32 M(-72.3%) |
| Sep 2010 | - | -$69.75 M(-110.2%) | $1.25 B(+48.1%) |
| Jun 2010 | - | $683.96 M(+173.9%) | $841.89 M(-1671.0%) |
| Mar 2010 | - | $249.74 M(-34.7%) | -$53.59 M(-86.4%) |
| Dec 2009 | -$395.03 M(+8.0%) | $382.62 M(-180.6%) | -$395.03 M(-68.2%) |
| Sep 2009 | - | -$474.43 M(+124.3%) | -$1.24 B(+43.2%) |
| Jun 2009 | - | -$211.51 M(+130.6%) | -$868.45 M(-4.3%) |
| Mar 2009 | - | -$91.71 M(-80.3%) | -$907.16 M(+147.9%) |
| Dec 2008 | -$365.87 M(+27.7%) | -$465.76 M(+368.2%) | -$365.87 M(-29.2%) |
| Sep 2008 | - | -$99.47 M(-60.2%) | -$516.75 M(+6.8%) |
| Jun 2008 | - | -$250.22 M(-155.7%) | -$483.93 M(-246.5%) |
| Mar 2008 | - | $449.58 M(-172.9%) | $330.39 M(-215.3%) |
| Dec 2007 | -$286.57 M | -$616.63 M(+825.2%) | -$286.57 M(-207.6%) |
| Sep 2007 | - | -$66.65 M(-111.8%) | $266.38 M(-41.4%) |
| Jun 2007 | - | $564.09 M(-437.0%) | $454.52 M(-191.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | -$167.38 M(+162.9%) | -$494.94 M(-17.5%) |
| Dec 2006 | -$599.77 M(-243.6%) | -$63.68 M(-152.4%) | -$599.77 M(-1.2%) |
| Sep 2006 | - | $121.49 M(-131.5%) | -$607.04 M(-51.9%) |
| Jun 2006 | - | -$385.37 M(+41.6%) | -$1.26 B(-940.5%) |
| Mar 2006 | - | -$272.21 M(+283.7%) | $150.24 M(-64.0%) |
| Dec 2005 | $417.74 M(-209.2%) | -$70.94 M(-86.7%) | $417.74 M(+44.6%) |
| Sep 2005 | - | -$534.29 M(-152.0%) | $288.89 M(-56.0%) |
| Jun 2005 | - | $1.03 B(<-9900.0%) | $657.26 M(-1022.7%) |
| Mar 2005 | - | -$4.71 M(-97.6%) | -$71.23 M(-81.4%) |
| Dec 2004 | -$382.43 M(+49.1%) | -$199.79 M(+20.4%) | -$382.43 M(+55.8%) |
| Sep 2004 | - | -$165.93 M(-155.5%) | -$245.44 M(+163.7%) |
| Jun 2004 | - | $299.20 M(-194.7%) | -$93.07 M(-80.5%) |
| Mar 2004 | - | -$315.91 M(+403.0%) | -$478.00 M(+86.4%) |
| Dec 2003 | -$256.43 M(-69.4%) | -$62.80 M(+363.2%) | -$256.43 M(-69.9%) |
| Sep 2003 | - | -$13.56 M(-84.2%) | -$851.29 M(-3.9%) |
| Jun 2003 | - | -$85.73 M(-9.1%) | -$886.13 M(-2.8%) |
| Mar 2003 | - | -$94.34 M(-85.7%) | -$911.30 M(+8.6%) |
| Dec 2002 | -$839.15 M(+231.4%) | -$657.66 M(+1258.9%) | -$839.15 M(+268.4%) |
| Sep 2002 | - | -$48.40 M(-56.4%) | -$227.78 M(-8.1%) |
| Jun 2002 | - | -$110.90 M(+399.5%) | -$247.99 M(+53.8%) |
| Mar 2002 | - | -$22.20 M(-52.0%) | -$161.22 M(-36.3%) |
| Dec 2001 | -$253.18 M(+140.0%) | -$46.29 M(-32.5%) | -$253.18 M(-6.9%) |
| Sep 2001 | - | -$68.61 M(+184.3%) | -$271.99 M(-8.0%) |
| Jun 2001 | - | -$24.13 M(-78.9%) | -$295.75 M(-4.4%) |
| Mar 2001 | - | -$114.16 M(+75.4%) | -$309.21 M(+193.1%) |
| Dec 2000 | -$105.49 M(-49.8%) | -$65.09 M(-29.5%) | -$105.49 M(+15.4%) |
| Sep 2000 | - | -$92.38 M(+145.8%) | -$91.38 M(+54.1%) |
| Jun 2000 | - | -$37.58 M(-142.0%) | -$59.30 M(-24.0%) |
| Mar 2000 | - | $89.56 M(-275.7%) | -$78.02 M(-62.9%) |
| Dec 1999 | -$210.08 M(+32.4%) | -$50.98 M(-15.5%) | -$210.08 M(-15.5%) |
| Sep 1999 | - | -$60.30 M(+7.1%) | -$248.68 M(+14.0%) |
| Jun 1999 | - | -$56.30 M(+32.5%) | -$218.18 M(+30.9%) |
| Mar 1999 | - | -$42.50 M(-52.6%) | -$166.68 M(+5.0%) |
| Dec 1998 | -$158.68 M(+2.2%) | -$89.58 M(+200.6%) | -$158.68 M(+42.6%) |
| Sep 1998 | - | -$29.80 M(+520.8%) | -$111.30 M(-21.8%) |
| Jun 1998 | - | -$4.80 M(-86.1%) | -$142.30 M(-20.9%) |
| Mar 1998 | - | -$34.50 M(-18.3%) | -$179.90 M(+15.9%) |
| Dec 1997 | -$155.20 M(+89.2%) | -$42.20 M(-30.6%) | -$155.20 M(-14.6%) |
| Sep 1997 | - | -$60.80 M(+43.4%) | -$181.65 M(+39.9%) |
| Jun 1997 | - | -$42.40 M(+332.7%) | -$129.85 M(+71.6%) |
| Mar 1997 | - | -$9.80 M(-85.7%) | -$75.65 M(-7.8%) |
| Dec 1996 | -$82.05 M(-11.1%) | -$68.65 M(+662.8%) | -$82.05 M(+45.2%) |
| Sep 1996 | - | -$9.00 M(-176.3%) | -$56.51 M(-11.2%) |
| Jun 1996 | - | $11.80 M(-172.8%) | -$63.61 M(-33.5%) |
| Mar 1996 | - | -$16.20 M(-62.4%) | -$95.71 M(+3.7%) |
| Dec 1995 | -$92.31 M(+31.3%) | -$43.11 M(+167.8%) | -$92.31 M(+70.0%) |
| Sep 1995 | - | -$16.10 M(-20.7%) | -$54.30 M(+108.9%) |
| Jun 1995 | - | -$20.30 M(+58.6%) | -$26.00 M(+2.4%) |
| Mar 1995 | - | -$12.80 M(+151.2%) | -$25.39 M(-63.9%) |
| Dec 1994 | -$70.30 M(+5.4%) | -$5.09 M(-141.8%) | -$70.30 M(-9.1%) |
| Sep 1994 | - | $12.20 M(-161.9%) | -$77.30 M(-24.2%) |
| Jun 1994 | - | -$19.70 M(-65.9%) | -$102.00 M(+49.8%) |
| Mar 1994 | - | -$57.70 M(+376.9%) | -$68.10 M(+2.1%) |
| Dec 1993 | -$66.70 M(+179.1%) | -$12.10 M(-3.2%) | -$66.70 M(-16.1%) |
| Sep 1993 | - | -$12.50 M(-188.0%) | -$79.50 M(+90.2%) |
| Jun 1993 | - | $14.20 M(-125.2%) | -$41.80 M(-26.7%) |
| Mar 1993 | - | -$56.30 M(+126.1%) | -$57.00 M(+138.5%) |
| Dec 1992 | -$23.90 M(-50.5%) | -$24.90 M(-198.8%) | -$23.90 M(-53.5%) |
| Sep 1992 | - | $25.20 M(-2620.0%) | -$51.40 M(-16.4%) |
| Jun 1992 | - | -$1.00 M(-95.7%) | -$61.50 M(-16.9%) |
| Mar 1992 | - | -$23.20 M(-55.7%) | -$74.00 M(+53.2%) |
| Dec 1991 | -$48.30 M(+63.7%) | -$52.40 M(-447.0%) | -$48.30 M(>+9900.0%) |
| Sep 1991 | - | $15.10 M(-211.9%) | -$200.00 K(-99.0%) |
| Jun 1991 | - | -$13.50 M(-640.0%) | -$21.00 M(+96.3%) |
| Mar 1991 | - | $2.50 M(-158.1%) | -$10.70 M(-63.7%) |
| Dec 1990 | -$29.50 M(-42.0%) | -$4.30 M(-24.6%) | -$29.50 M(+17.1%) |
| Sep 1990 | - | -$5.70 M(+78.1%) | -$25.20 M(+29.2%) |
| Jun 1990 | - | -$3.20 M(-80.4%) | -$19.50 M(+19.6%) |
| Mar 1990 | - | -$16.30 M | -$16.30 M |
| Dec 1989 | -$50.90 M | - | - |
FAQ
- What is Biogen annual cash flow from investing activities?
- What is the all time high annual CFI for Biogen?
- What is Biogen annual CFI year-on-year change?
- What is Biogen quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Biogen?
- What is Biogen quarterly CFI year-on-year change?
- What is Biogen TTM cash flow from investing activities?
- What is the all time high TTM CFI for Biogen?
- What is Biogen TTM CFI year-on-year change?
What is Biogen annual cash flow from investing activities?
The current annual CFI of BIIB is -$4.10 B
What is the all time high annual CFI for Biogen?
Biogen all-time high annual cash flow from investing activities is $1.58 B
What is Biogen annual CFI year-on-year change?
Over the past year, BIIB annual cash flow from investing activities has changed by -$5.68 B (-360.12%)
What is Biogen quarterly cash flow from investing activities?
The current quarterly CFI of BIIB is -$1.18 B
What is the all time high quarterly CFI for Biogen?
Biogen all-time high quarterly cash flow from investing activities is $1.67 B
What is Biogen quarterly CFI year-on-year change?
Over the past year, BIIB quarterly cash flow from investing activities has changed by -$1.65 B (-353.18%)
What is Biogen TTM cash flow from investing activities?
The current TTM CFI of BIIB is -$1.43 B
What is the all time high TTM CFI for Biogen?
Biogen all-time high TTM cash flow from investing activities is $1.60 B
What is Biogen TTM CFI year-on-year change?
Over the past year, BIIB TTM cash flow from investing activities has changed by +$561.10 M (+28.14%)